Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3145 results found
Expand All
Apply All
3145 results found

What to expect from the Biden administration’s trade agenda
Share
Good Day BIO Newsletter  •  March 19, 2021
Ending the week with Katherine Tai’s historic confirmation as U.S. Trade Representative and what we can expect from the administration’s trade agenda, as well as what policymakers and federal health officials said this week about COVID-19 vaccines. We also meet the Japanese American researcher whose work led to the discovery of the polio vaccine. (975 words, 4 minutes, 52 seconds)
Read More

BIO Welcomes Collaboration With New HHS, USTR Leaders
Share
Human Health, Cost & Value of Biopharmaceuticals  •  Press Release  •  March 18, 2021
The Biotechnology Innovation Organization (BIO) welcomes the confirmations this week of Katherine Tai to the position of U.S. Trade Representative (USTR) and Xavier Becerra to lead the Department of Health and Human Services (HHS).  The United States leads the world in biotechnology innovation, creating hundreds of thousands of good jobs. Our members are critical to addressing global health, agricultural, nutrition, and climate sustainability challenges. This includes the very important task of bringing an end to the current COVID-19 pandemic. On the confirmation of HHS Secretary Xavier Becerra, Dr. Michelle McMurry-Heath, president and CEO of BIO, released the following statement: “We congratulate Mr. Becerra on his confirmation to lead the Department of Health and Human Services. “HHS has already played, and will continue to play, a critical role in ending this global pandemic, addressing health disparities, and finding solutions to other issues facing our health system. “BIO looks forward to working with Mr. Becerra and his colleagues in HHS to defeat COVID-19, prepare for future pandemics, and promote patient-centered solutions that prioritize access and lasting biomedical innovation.” On the confirmation of Katherine Tai to USTR, Dr. McMurry-Heath said: “Trade policy has a critical role to play in helping the biotech sector fulfill its potential for the American worker and for humanity. “The hundreds of small companies that comprise our sector especially need help in global markets to ensure a level playing field and to protect against the unfair appropriation of world-leading U.S. technology. “Moreover, the importance of maintaining resilient and diverse supply chains, and refraining from export restrictions for COVID products is crucial as our sector works with global partners through COVAX and other initiatives to ensure that patients around the world get access to COVID vaccines and treatments. “We look forward to working with Ambassador…
Read More

BIO Testimony to House Energy and Commerce Subcommittee Hearing on the CLEAN Future Act
Share
Agriculture & Environment, Food & Farm Innovation, Sustainable Fuels  •  Letters, Testimony & Comments  •  March 18, 2021
The Biotechnology Innovation Organization (BIO) is pleased to submit a statement for the record to the United States House of Representatives Committee on Energy and Commerce Subcommittee on Environment and Climate Change hearing entitled, "The CLEAN Future Act: Industrial Climate Policies to Create Jobs and Support Working Communities." To tackle the climate crisis, it is crucial to lead with science and U.S. innovation. We must incentivize the adoption of innovative and sustainable technologies and practices and streamline and expedite regulatory pathways for breakthrough technology solutions to reduce carbon in hard-to-abate sectors.  BIO is committed to working with Committee, Congress, and the Administration to address the climate crisis. We urge to support policy that advances pioneering technology breakthroughs. With science, we can return our Nation and the world to health and prosperity by taking bold and drastic action to address the climate crisis.       
Read More

Action to improve U.S. R&D policy
Share
Good Day BIO Newsletter  •  March 18, 2021
A busy Thursday with a look at U.S. R&D policy, U.K. gene editing policy, and confirmations and hearings to watch in Congress. (1,000 words, 5 minutes)
Read More

BIO Letter to DEFRA Consultation on the Regulation of Genetic Technologies
Share
Agriculture & Environment, Food & Farm Innovation  •  Letters, Testimony & Comments  •  March 17, 2021
The Biotechnology Innovation Organization (BIO) welcomes the United Kingdom’s (UK) consultation on the application of genome editing in the breeding of plants and animals.  The UK has the unique opportunity to be the first country within Europe to establish a path forward for genome editing technologies, establishing the UK as a regional and global leader in this technology, and providing farmers in England new powerful tools to enable agriculture to be a solution to the ever-growing threat of climate change.  As the UK considers broad reform of legislation with respect to GM technology, BIO urges the UK to join with key trading partners to chart a path forward where science and technology can be fully leveraged to confront climate change and enable the sustainable production of food globally, particularly in regions of the world most susceptible to the environmental and economic threats posed by climate change.  As the policy environment develops, BIO and its members are eager to be a resource to help the UK government advance its innovation and sustainability goals.  
Read More

A policy win for vulnerable patients
Share
Good Day BIO Newsletter  •  March 17, 2021
Another St. Patrick’s Day at home—thank biotech for beer! Today, we have news from CMS that’s a win for the most vulnerable patients, as well as a look at how biotech can help solve growing food insecurity.  (780 words, 3 minutes, 54 seconds)
Read More

Where things stand
Share
Good Day BIO Newsletter  •  March 16, 2021
USDA is seeking input on “climate-smart agriculture and forestry strategy”—and BIO’s on it. We also have positive headlines from BIO members working on COVID-19 vaccines and therapeutics as well as news from the Capitol. (859 words, 4 minutes, 17 seconds) P.S. BIO Digital registration opens today! There are big savings if you register by April 11. Get the details.
Read More

Why community health centers matter
Share
Good Day BIO Newsletter  •  March 15, 2021
Today, we examine the stimulus provisions for community health centers and why they matter, plus how biotechnology can improve soil health and rural economies. Have a great week! (790 words, 3 minutes, 57 seconds)
Read More

New Mexico’s Senate passes clean fuel standard
Share
Good Day BIO Newsletter  •  March 12, 2021
Closing a long week with good news: COVID-19 relief is coming, New Mexico’s Senate passed a clean fuel standard, and we might be able to plan July 4th barbecues. In the meantime, continue following the CDC’s guidelines, get your vaccine when you’re eligible, and enjoy the weekend. (787 words, 3 minutes, 56 seconds)
Read More

New Mexico's Clean Fuel Standard Will Ignite State's Green Economy
Share
Agriculture & Environment, Sustainable Fuels  •  Press Release  •  March 11, 2021
Albuquerque, NM (March 11, 2021) — Today, the Biotechnology Innovation Organization (BIO) released the following statement applauding the passage of a clean fuel standard in New Mexico: “The passage of a clean fuel standard in New Mexico will have a profound impact on igniting the green economy in the nation’s third-largest oil-producing state,” said Gene Harrington, BIO’s Director of State Government Affairs. “Not only will New Mexico’s clean fuel standard help to reduce emissions, it will provide new revenue streams for farmers to sell their crops and animal waste for fuel and will incentivize sustainable agriculture. And the increasing support for a clean fuel standard from the private sector is further proof that policies supporting sustainable fuels are also good for business. BIO and the New Mexico Clean Fuels Coalition look forward to working with state lawmakers to implement the clean fuel standard and begin decarbonizing the state’s transportation sector.”
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 191
  • 192
  • 193
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO Investment and Growth Summit
BIO Partnering™ for Oncology
BIO International Convention
BIO Partnering™ at JPM Week
BIO Patient Advocacy Changemakers Events
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO